FindTrial
Sign In

Protective layer in hypospadias surgery

Autologous platelet-rich fibrin patch in hypospadias repair- A randomised control trial. - AHRT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/08/015458
Enrollment
30
Registered
2018-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pediatric patients having distal or midpenile hypospadias till the age of 14 years

Interventions

Intervention1: APRF patch: After neourethra creation patients randomised to receive the patch will receive APRF patch before skin closure Control Intervention1: No APRF patch: After neourethra creatio

Sponsors

Dr Anjan Dhua
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Primary cases of Distal and Mid-penile hypospadias suitable for Tubularised incised plate urethroplasty operation.

Exclusion criteria

Exclusion criteria: Non-availability of consent Those requiring additional coverage of neo-urethra like tunica vaginalis flap etc. and Follow up of less than 3 months.

Design outcomes

Primary

MeasureTime frame
To evaluate the urethrocutaneous fistula (UCF) rate in tubularised incised plate urethroplasty (TIPU) repair of mid and distal primary hypospadias cases after the use of autologous platelet-rich fibrin (APFR) patch as a barrier over neourethral stitch line.Timepoint: 6months—

Secondary

MeasureTime frame
To compare the above parameters between the 2 groupsTimepoint: 6months;To evaluate the type of UCF (large vs small) in group ATimepoint: 6months;To evaluate the wound dehisence rate in group ATimepoint: 6 months—

Countries

India

Contacts

Public ContactANJAN DHUA

AIIMS, Delhi

anjandhua@hotmail.com9871568690

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026